title: Statins and atrial fibrillation in patients with left ventricular dysfunction: insights from the AF-CHF trial.
authors.forename: Linda
authors.initials: L
authors.lastname: Koutbi
authors.forename: Denis
authors.initials: D
authors.lastname: Roy
authors.forename: Mario
authors.initials: M
authors.lastname: Talajic
authors.forename: Lucie
authors.initials: L
authors.lastname: Blondeau
authors.forename: Frédéric
authors.initials: F
authors.lastname: Franceschi
authors.forename: Lena
authors.initials: L
authors.lastname: Rivard
authors.forename: Laurent
authors.initials: L
authors.lastname: Macle
authors.forename: Jason G
authors.initials: JG
authors.lastname: Andrade
authors.forename: Peter G
authors.initials: PG
authors.lastname: Guerra
authors.forename: Bernard
authors.initials: B
authors.lastname: Thibault
authors.forename: Marc
authors.initials: M
authors.lastname: Dubuc
authors.forename: Paul
authors.initials: P
authors.lastname: Khairy
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors